Investigation of factors related to amyotrophic lateral sclerosis (ALS)

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel, focusing on differences among ethnic subgroups, immigrant versus native-born populations, and military service profiles. Clinical features will be recorded during routine visits throughout the disease course, allowing for a comprehensive database to correlate these features with potential epidemiological factors. The study aims to gather detailed clinical data, including ALSFRS-R scores and neurological assessments, to better understand the disease's patterns and influences.

Why it matters

Who can join: the full rules

Inclusion Criteria:

\- Suspected, possible, probable ,definite ALS

Exclusion Criteria:

\-

Where it's running

• Hadassah Medical Organisation
  Jerusalem, Israel Recruiting

Study contacts

• Principal investigator: Marc Gotkine, MBBS — Hadassah Medical Organization
• Study coordinator: Marc Gotkine, MBBS
• Email: marc@gotkine.com
• Phone: +972507874692

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Decoding Mandarin speech features from brain-surface signals

  This project will try to decode imagined Mandarin speech, including lexical tones, from high-density brain-surface (ECoG) signals in adult patients who are having clinically indicated cortical electrode placement.

  Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine · Hangzhou, Zhejiang · NCT07460037

• At-home cortico-spinal tDCS for ALS.

  This treatment tests whether daily at-home cortico-spinal tDCS can slow nerve damage and symptoms in adults with early ALS.

  Recruiting University of Trieste · Trieste, Trieste · NCT07006571

• Cell therapy using induced pluripotent stem cells for ALS treatment

  This study is testing a new cell therapy using stem cells to see if it can safely help people with ALS feel better.

  Recruiting Shanghai East Hospital · Shanghai, Shanghai Municipality · NCT06765564

• Multicenter study using MRI to identify biomarkers in ALS patients

  This study is trying to see if brain scans and blood tests can help track how ALS changes over time in patients compared to healthy people.

  Recruiting at 3 sites University of Minnesota · Gainesville, Florida and 2 other locations · NCT06735014

• Evaluating AMX0114 for treating ALS in adults

  This study is testing a new drug called AMX0114 to see if it is safe and how well it works for adults with ALS.

  Recruiting at 14 sites Phase 1 Amylyx Pharmaceuticals Inc. · La Jolla, California and 13 other locations · NCT06665165

• Using a brain-computer interface to help people with tetraplegia communicate

  This study is testing a new brain-computer interface to help people with tetraplegia communicate more easily using a tablet.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT06511934

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.